CBUS CIBUS INC

Cibus to Participate in Upcoming August Investor Events

Cibus to Participate in Upcoming August Investor Events

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announced its participation in the following August investor events.

  • Canaccord Genuity 44th Annual Growth Conference, Boston, MA – August 13-14, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer will host a presentation beginning at 12:30 p.m. ET (9:30 a.m. PT) on August 14.

Webcast link:

  • Sidoti Micro Cap Conference, Virtual – August 14-15, 2024: Mr. Riggs and Mr. Beetham, will be meeting with investors and host a virtual presentation beginning at 3:15 p.m. ET (12:15 p.m. PT) on August 14. A live audio webcast of the presentation will be accessible through the link below:

Webcast link:

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop traits to license to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. In total, Cibus has developed a pipeline of six productivity traits. It is commercializing its Pod Shatter Reduction trait in Canola and is a leader in weed management traits in Rice with its HT1 and HT3 traits with customers such as Loveland Products (Nutrien Ltd.) and Interoc S.A in the United States and Latin America. Its recent development of stacked herbicide tolerant traits in rice is an important milestone in developing better weed solutions in rice. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

CIBUS CONTACTS:

INVESTOR RELATIONS

Karen Troeber



858-450-2636

Jeff Sonnek – ICR

MEDIA RELATIONS



(619) 849-6009

Colin Sanford



203-918-4347



EN
12/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE

Cibus to Report Third Quarter 2025 Financial Results on November 13, 2...

Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Qu...

 PRESS RELEASE

Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New S...

Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced its agreement with AgVayā, a strategic growth advisory fir...

 PRESS RELEASE

Cibus Announces Positive Field Trial Results for Second-Generation Her...

Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola Field testing confirms efficacy of HT2 trait in Canola under real-world conditions HT2 trait will be offered to potential seed licensing partners for introduction into commercial Canola seed products SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company developing and licensing advanced gene edited plant traits that enable improved productivity, higher yields, lower input costs, and more sustainable farmin...

 PRESS RELEASE

Cibus Announces the Election of Kimberly A. Box to Board of Directors

Cibus Announces the Election of Kimberly A. Box to Board of Directors Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board ...

 PRESS RELEASE

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agric...

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025 SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City. The event, titled “Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutio...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch